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ABSTRACT
Purpose: We sought to determine the prevalence of trachoma in each local government area
(LGA) of Benue State, Nigeria.
Methods: Two-stage cluster sampling was used to conduct a series of 23 population-based
prevalence surveys. LGAs were the evaluation units surveyed. In each LGA, 25 households were
selected in each of 25 clusters, and individuals aged 1 year and above resident in those house-
holds were invited to be examined for trachoma. Data on access to water and sanitation were also
collected at household level.
Results: A total of 91,888 people were examined from among 93,636 registered residents across
the 23 LGAs. The LGA-level prevalence of trachomatous inflammation—follicular (TF) in 1–9 year
olds ranged from 0.3% to 5.3%. Two LGAs had TF prevalences of 5.0–9.9%. The LGA-level
prevalence of trichiasis in ≥15-year-olds ranged from 0.0% to 0.35%. Access to improved drinking
water sources ranged from 0% in Gwer West to 99% in Tarka, while access to improved sanitation
ranged from 1% in Gwer West to 92% in Oturkpo.
Conclusion: There is a need for public health-level interventions against trachoma in three LGAs
of Benue State.
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Introduction
Trachoma is the world’s most common infectious cause
of blindness.1 The disease is caused by repeated bouts2
of infection with the obligate intracellular bacterium
Chlamydia trachomatis, which passes from person to
person through contaminated hands, through clothes
and bedding, and via the eye-seeking fly, Musca
sorbens.3 Trachoma disappeared from most developed
countries decades ago, but it continues to be a public
health problem in much of Africa,4,5 including
Nigeria.6
In 1996, the World Health Organization (WHO)
established the WHO Alliance for the Global
Elimination of Trachoma by 2020 (GET2020).7 The
comprehensive strategy to achieve elimination goes by
the acronym “SAFE,” which represents surgery, anti-
biotics, facial cleanliness, and environmental
improvement.8 The need for SAFE strategy implemen-
tation is determined on the basis of prevalence esti-
mates of trichiasis in ≥15-year-olds and trachomatous
inflammation—follicular (TF) in 1-9-year-olds.9 WHO
recommends use of the SAFE strategy until elimination
threshold prevalences (trichiasis <0.2% in ≥15-year-
olds and TF <5% in 1-9-year-olds) are reached in
each formerly endemic district.9,10
From 2012 to 2016, members of the WHO Alliance
for GET2020 made considerable progress in baseline
mapping of suspected trachoma-endemic districts
worldwide within the Global Trachoma Mapping
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Project (GTMP).11 Its goal was to provide a complete
picture of the global burden of trachoma, enabling all
stakeholders to see where work was needed to achieve
elimination as a public health problem.12 Though many
other states of Nigeria had previously been mapped for
trachoma,13–25 no population-based surveys had been
undertaken in Benue State, despite the fact that SAFE
interventions had been required in neighbouring
Nasarawa State, including in a number of bordering
local government areas (LGAs).13
The work described here was therefore conducted to
(a) determine the LGA-level prevalence of TF and
trichiasis in Benue, (b) determine LGA-level prevalence
of access to improved water and sanitation, and (c)
estimate the likely number of doses of antibiotics and
the number of people to be managed for trichiasis that
will be needed in Benue State in order to meet the
targets of GET2020.
Methods
Study design and setting
Surveys were undertaken between April and September
2014, following standard GTMP procedures, as
described previously.26 Benue State, located in the
north–central zone of Nigeria, has an ethnically diverse
population, which was estimated to total 4.3 million
people at the last (2006) census.27 Benue contains 23
LGAs within a land area of 34,059 km.2
Field team preparation
Teams were trained using version 2 of the GTMP
training system.28 To be certified to participate in the
surveys, graders were required to pass a 50-subject
inter-grader agreement test in the field, with the assess-
ments of a GTMP-certified grader trainer used as the
reference. Data recorders were also required to pass a
test before deployment.26
Sampling and field procedures
LGAs were the units of evaluation. Two-stage cluster
sampling was undertaken. We used villages as first-
stage clusters, choosing 25 of them from each of the
23 LGAs, with probability of selection proportional to
village size.9 From each village, 25 households were
selected using the random walk technique, though we
are aware of its limitations, detailed elsewhere.18,29–31
With a resident’s help, the centre of the village was
located and from that starting position a direction for
household sampling was selected by spinning a pen and
letting it fall to the ground. All residents aged ≥1 year
living in the 25 households found on the heading
indicated by the pen’s tip were invited to participate.
This sampling strategy was designed to promote
recruitment of a sample of at least 1019 children aged
1–9 years, as outlined previously.26
At each household, we collected GPS data on house-
hold location, the type of and distance to sources of
drinking and washing water in the dry season, the
setting (e.g., type of shared or private latrine, outside
near the home, in the bush or field) in which household
adults usually defecated, the presence or absence of a
handwashing facility within 15 m of the latrine (if a
latrine was used), and the presence or absence of water
and soap at the handwashing facility (if a handwashing
facility was present). This information was obtained
through questions asked of a household key informant
and by direct inspection.28 Questions conformed clo-
sely to those used up to the year 2015 by the WHO/
UNICEF Joint Monitoring Programme for Water
Supply and Sanitation.32,33 From each participant, we
collected data on age, gender, and presence or absence
of trichiasis, TF, and trachomatous inflammation—
intense (TI).34
Operational definitions
Graders adhered to the definitions of signs in the WHO
simplified trachoma grading system.34 An “improved”
water source was defined as one that, by nature of its
construction, adequately protects the water from out-
side contamination, in particular from faecal matter.
An improved sanitation facility was defined as one
that hygienically separates human excreta from
human contact.32
Data management
Data were cleaned by an independent data manager
(RW), approved by the health ministry, then analysed;
outputs were again approved by health ministry.26
Cluster-level proportions of children with TF were
adjusted for age in 1-year bands, and proportions of
adults with trichiasis were adjusted for gender and age
in 5-year bands; local 2006 census data27 were used for
this adjustment process. LGA-level prevalences were
calculated as the means of adjusted cluster-level pro-
portions. Confidence intervals (CIs) were determined
by bootstrapping: sets of 25 adjusted cluster-level pro-
portions were selected, with replacement, over 10,000
replications, then the 2.5th and 97.5th percentiles of the
ordered means of those sets formed the lower and
upper bounds of the CI.
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Ethical considerations
Surveys were approved by the Ethics Committee of
the London School of Hygiene & Tropical Medicine
(6319) and the National Health Research Ethics
Committee of Nigeria (NHREC/01/01/2007). The
Benue State Ministry of Health gave permission for
work to proceed and oversaw its implementation.
Informed verbal consent was obtained from each
participant or their parent or guardian. We adhered
to the principles of the Declaration of Helsinki.35 All
data were collected into the Open Data Kit Android
smartphone application, LINKS-GTMP, encrypted
during transport, and stored in a password-pro-
tected database in the cloud to ensure confidential-
ity, fidelity, and accessibility.26,36 Subjects with
active trachoma were given antibiotics37; those who
needed trichiasis surgery38 were referred to the
nearest provider.
Results
A total of 93,636 participants were enumerated across
the 23 LGAs; 91,888 (98%) consented to participate and
were examined, 602 refused participation, and 1146
were absent. The age of participants ranged from
1 year to 100 years (mean 18.3 years).
Prevalence of trachoma
Some 43,640 1-9-year-olds were examined. The LGA-
level prevalence of TF among 1-9-year-olds ranged
from 0.3% to 5.3% (Table 1). Two LGAs had TF pre-
valences of 5.0–9.9% among 1-9-year-olds. The remain-
ing LGAs had TF prevalences of <5% (Table 1).
A total of 36,802 persons aged ≥15 years were exam-
ined. There were 42 adults with trichiasis, giving an
overall (unadjusted) prevalence of trichiasis of 0.11% in
examined ≥15-year-olds. The LGA-level trichiasis pre-
valence ranged between 0% (15 LGAs) and 0.35% (95%
CI 0.12–0.50) in Okpokwu (Table 1). Twenty-one (91%
of) LGAs had trichiasis prevalence estimates of <0.2%
in adults. In the two LGAs with prevalence estimates of
≥0.2%, the estimated number of individuals needed to
be managed to reduce the prevalence to less than the
elimination threshold, ignoring incident disease and
mortality in those with trichiasis, is 869.
Access to water and sanitation
More than half of all participants (57%) lived in house-
holds without a latrine facility, in which adult residents
defecated either in the bush or in the open near the
household. At LGA level, the proportion of households
with access to improved sanitation ranged from 1% in
Gwer West to 92% in Oturkpo. In only two of 23 LGAs
Table 1. Local Government Area-level prevalence of trichiasis in ≥15-year-olds and prevalence of trachomatous inflammation—
follicular (TF) in 1-9-year-olds, Global Trachoma Mapping Project, Benue State, Nigeria, April–September 2014.
Local
Government
Area
Number of
≥15-year-
olds
examined
Number of
≥15-year-
olds with
trichiasis
Prevalence of
trichiasis in
≥15-year-olds,
% (95% CI)a
Estimated
total
population
aged
≥15 years
Estimated
trichiasis
backlog
Number of persons that
need trichiasis
management to achieve
elimination threshold
Number of
1-9-year-
olds
examined
Number
of 1-9-
year-olds
with TF
Prevalence of
TF in 1-9-
year-olds, %
(95% CI)b
Ado 2087 11 0.19 (0.07–0.34) 97,142 187 0 3449 120 3.0 (2.1–4.2)
Agatu 1572 0 0 60,493 0 0 4053 23 0.5 (0.3–0.7)
Apa 1426 0 0 51,001 0 0 2109 8 0.3 (0.1–0.5)
Buruku 1364 0 0 108,425 0 0 1309 17 1.8 (0.7–3.4)
Gboko 1750 0 0 202,010 0 0 1235 5 0.3 (0.1–0.7)
Guma 997 1 0.01 (0.00–0.02) 101,355 6 0 1708 80 4.2 (3.2–5.4)
Gwer East 1709 5 0.23 (0.00–0.52) 90,299 210 29 1433 91 5.3 (3.3–7.7)
Gwer West 1175 0 0 63,901 0 0 1373 62 4.6 (2.9–6.6)
Katsina-Ala 1600 10 0.19 (0.03–0.43) 120,884 228 0 1172 28 1.9 (1.0–2.7)
Konshisha 1302 0 0 120,147 0 0 1972 17 0.8 (0.4–1.4)
Kwande 1265 0 0 133,246 0 0 1442 11 0.6 (0.3–0.9)
Logo 2938 0 0 89,816 0 0 2059 17 0.7 (0.3–0.9)
Makurdi 1879 0 0 176,405 0 0 1378 27 1.8 (0.7–2.8)
Obi 1883 0 0 52,081 0 0 3821 95 2.3 (1.5–3.2)
Ogbadibo 1657 1 0.01 (0.00–0.02) 70,791 5 0 1042 41 3.5 (1.8–5.1)
Ohimini 2644 1 0.03 (0.00–0.09) 37,847 11 0 3072 23 0.8 (0.5–1.2)
Oju 1481 0 0 92,435 0 0 1189 21 1.5 (0.8–2.3)
Okpokwu 1152 12 0.35 (0.12–0.50) 94,565 333 144 1012 8 0.5 (0.1–0.8)
Oturkpo 1322 0 0 148,700 0 0 1462 9 0.7 (0.2–1.5)
Tarka 771 0 0 41,295 0 0 3145 34 1.6 (0.8–2.7)
Ukum 1341 0 0 115,173 0 0 1111 66 5.2 (3.6–7.0)
Ushongo 1545 1 0.08 (0.00–0.25) 101,497 84 0 1701 24 1.1 (0.4–2.3)
Vandeikya 1942 0 0 125,214 0 0 1393 48 2.8 (1.5–4.7)
Total 36,802 42 2,294,722 1,064 173 43,640 875
aAdjusted for gender and age, in 5-year bands.
bAdjusted for age, in 1-year bands.
CI, confidence interval.
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did ≥80% of households have access to improved sani-
tation facilities, while only one (Tarka) of 23 LGAs had
≥80% of households with access to an improved water
source (Table 2).
Discussion
Trachoma remains endemic in many parts of Nigeria.
Many LGAs in states other than Benue need to implement
the “SAFE” strategy to eliminate the condition as a public
health problem. We have surveyed each of Benue State’s
23 LGAs, and found prevalence estimates of TF and
trichiasis that are very modest in comparison to more
northern states of Nigeria,13,14,17,22–25,39,40 or other set-
tings in sub-Saharan Africa.41–45 Only two LGAs (Gwer
East and Okpokwu) require public health-level imple-
mentation of the S component of the SAFE strategy.
Only two LGAs (Gwer East and Ukum) had TF preva-
lences suggesting a need for the A, F, and E components
of SAFE. Both of the latter LGAs had TF prevalence
estimates just above the 5% elimination threshold, with
95%CI lower bounds from 3.0% to 4.0%, and it is emi-
nently possible that these estimates are simply statistical
outliers, rather than representations of ongoing C. tracho-
matis transmission that should trigger public health con-
cern. However, hard thresholds for elimination must be
(and have been) defined, and implementation of inter-
ventions for neglected tropical disease elimination is jus-
tifiable in such cases on the basis of apparent very low
risk, high community acceptability, and a range of
benefits to communities beyond simply bringing about
the end of the diseases in question.46–52
Trachoma prevalence was low in Benue State despite
inadequate access to water and sanitation (Table 2).
Though recent work53,54 has begun to explore levels
of community WASH coverage that might associate
with lower risk of active trachoma, it does not necessa-
rily follow that particular coverage levels are necessary
or sufficient for active trachoma to be eliminated.
Regardless, water and sanitation are human rights,
and extension of these services to all residents of
Benue should be vigorously pursued.
Our surveys had some limitations, including the
relatively low numbers of adults examined in several
LGAs (771 in Tarka, 997 in Guma; in both of these
LGAs no examined adults had trichiasis) and the lack
of data on the presence or absence of trachomatous
conjunctival scar in eyes diagnosed as having trichiasis.
However, the very low prevalences of trichiasis
observed almost uniformly across the state would sup-
port an assertion that trachoma is close to being elimi-
nated in this setting.
Implementation of community-based trichiasis sur-
gery in the two LGAs observed to have above-elimina-
tion-threshold prevalences will help to both maximize
the chance that impact surveys will return prevalence
estimates below the threshold, and prepare the health
system for routine delivery of such services, as and
when needed, in the post-validation phase. Human
resources, training, equipment, consumables, and fund-
ing for trichiasis case finding will be required. Although
Table 2. Household-level access to improved water and sanitation facilities by Local Government Area, Global Trachoma Mapping
Project, Benue State, Nigeria, April–September 2014.
Local Government
Area
Access to an improved drinking water
source, %
Washing water source (improved or unimproved) <1 km from
household (%)
Access to improved
sanitation, %
Ado 21 48 29
Agatu 7 36 12
Apa 1 100 19
Buruku 69 82 17
Gboko 36 54 35
Guma 24 43 16
Gwer East 67 50 11
Gwer West 0 9 1
Katsina-Ala 63 75 53
Konshisha 56 68 5
Kwande 73 88 26
Logo 33 31 49
Makurdi 66 41 53
Obi 27 14 3
Ogbadibo 44 99 34
Ohimini 13 61 25
Oju 61 13 2
Okpokwu 3 58 80
Oturkpo 49 99 93
Tarka 99 74 43
Ukum 45 68 12
Ushongo 68 7 17
Vandeikya 57 100 16
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we estimated the number of cases of trichiasis that
would need to be appropriately managed in order to
achieve sub-threshold trichiasis prevalences (Table 1),
we caution that such calculations ignore incident cases
and are therefore only valid if interventions are con-
ducted immediately after the prevalence survey under-
lying the calculations.
Trachoma is a public health problem in some LGAs
of Benue State, and relevant stakeholders are urged to
support the Ministry of Health to tackle the problem in
order to achieve trachoma’s elimination as a public
health problem.
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